126 related articles for article (PubMed ID: 35163139)
21. Moving out of CF
Witoszka K; Matalińska J; Misicka A; Lipiński PFJ
ChemMedChem; 2023 Dec; 18(23):e202300315. PubMed ID: 37821725
[TBL] [Abstract][Full Text] [Related]
22. Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers.
Kanduluru AK; Low PS
Mol Pharm; 2017 Nov; 14(11):3859-3865. PubMed ID: 28969417
[TBL] [Abstract][Full Text] [Related]
23. [
Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Evaluation of
Zhao R; Ploessl K; Zha Z; Choi S; Alexoff D; Zhu L; Kung HF
Mol Pharm; 2020 Dec; 17(12):4589-4602. PubMed ID: 33108189
[TBL] [Abstract][Full Text] [Related]
25. Design, preparation and biological evaluation of a
Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
[TBL] [Abstract][Full Text] [Related]
26. The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y.
Maurin M; Garnuszek P; Baran P; Pawlak D; Mikołajczak R
Nucl Med Rev Cent East Eur; 2015; 18(2):51-5. PubMed ID: 26315862
[TBL] [Abstract][Full Text] [Related]
27. Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.
Nyman MJ; Eskola O; Kajander J; Vahlberg T; Sanabria S; Burns D; Hargreaves R; Solin O; Hietala J
Int J Neuropsychopharmacol; 2007 Apr; 10(2):219-29. PubMed ID: 16573846
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, proteolytic stability, and
Kaur J; Arroub K; Drzezga A; Schomäcker K; Mathur S
Org Biomol Chem; 2021 Nov; 19(45):9849-9854. PubMed ID: 34755753
[TBL] [Abstract][Full Text] [Related]
29. Illuminating the structural basis of human neurokinin 1 receptor (NK1R) antagonism through classical all-atoms molecular dynamics simulations.
Mishra S; Rout M; Singh MK; Dehury B; Pati S
J Cell Biochem; 2023 Nov; 124(11):1848-1869. PubMed ID: 37942587
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
Beaino W; Nedrow JR; Anderson CJ
Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro evaluation of
Zhang J; Wang Z; Liu H; Cai L; Feng Y; Zhou L; Wei H; Xie Y; Chen Y
Hell J Nucl Med; 2019; 22(2):103-110. PubMed ID: 31273351
[TBL] [Abstract][Full Text] [Related]
32. The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.
Majkowska-Pilip A; Halik PK; Gniazdowska E
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31480582
[TBL] [Abstract][Full Text] [Related]
33. An assessment tumor targeting ability of (177)Lu labeled cyclic CCK analogue peptide by binding with cholecystokinin receptor.
Cho EH; Lim JC; Lee SY; Jung SH
J Pharmacol Sci; 2016 Jul; 131(3):209-14. PubMed ID: 27430985
[TBL] [Abstract][Full Text] [Related]
34. Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
Lymperis E; Kaloudi A; Sallegger W; Bakker IL; Krenning EP; de Jong M; Maina T; Nock BA
Bioconjug Chem; 2018 May; 29(5):1774-1784. PubMed ID: 29664606
[TBL] [Abstract][Full Text] [Related]
35. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
[TBL] [Abstract][Full Text] [Related]
36. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
37. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Bailey GA; Price EW; Zeglis BM; Ferreira CL; Boros E; Lacasse MJ; Patrick BO; Lewis JS; Adam MJ; Orvig C
Inorg Chem; 2012 Nov; 51(22):12575-89. PubMed ID: 23106422
[TBL] [Abstract][Full Text] [Related]
38. Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.
Song J; Huang S; Ma P; Zhang B; Jia B; Zhang W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127353. PubMed ID: 32631551
[TBL] [Abstract][Full Text] [Related]
39. Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases.
Roosterman D; Cottrell GS; Schmidlin F; Steinhoff M; Bunnett NW
J Biol Chem; 2004 Jul; 279(29):30670-9. PubMed ID: 15128739
[TBL] [Abstract][Full Text] [Related]
40. Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.
Nyman M; Eskola O; Kajander J; Jokinen R; Penttinen J; Karjalainen T; Nummenmaa L; Hirvonen J; Burns D; Hargreaves R; Solin O; Hietala J
J Affect Disord; 2019 Jan; 242():188-194. PubMed ID: 30193189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
